晨间信号Morning Signal
《科学家》 第40卷 第2期 · 2026年夏季刊 · 中文解读

家庭微生物组检测面临监管空白

Regulatory Gaps Plague At-Home Microbiome Tests · Sneha Khedkar
约 19 分钟Features在小程序里点播,20 到 60 分钟做好
这篇讲什么
本文探讨了直接面向消费者的微生物组检测在科学和监管方面仍不完善,凸显了制定更好标准和监督的必要性。
原文开头
Despite its popularity, the science and regulations surrounding microbiome testing are still catching up, highlighting the need for better standards and oversight. BY SNEHA KHEDKAR About four years ago, Stephanie Servetas, a microbiologist at the National Institute of Standards and Technology (NIST), and her colleagues set out on a unique quest: They planned to mail a poop sample to seven companies that offered at-home microbiome test kits. Direct-to-consumer (DTC) microbiome tests have gained traction in recent times because of increasing evidence linking the microbiome to conditions such as cancer, obesity, and mental health.1-3 Generally, DTC microbiome testing companies mail a home test kit—which costs anywhere between $100 and $1000—to consumers, who then mail back stool samples. …
摘自《科学家》(The Scientist)第40卷 第2期 · 2026年夏季刊,Sneha Khedkar。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章